Ebola clinical trials: Five lessons learned and a way forward

Abstract

Get full access to this article

View all access options for this article.

References

World Health Organization. Statement on the 1st meeting of the IHR Emergency Committee on the 2014 Ebola outbreak in West Africa, http://www.who.int/mediacentre/news/statements/2014/ebola-20140808/en/ (2014, accessed 10 October 2015).

Meltzer

Atkins

Santibanez

. Estimating the future number of cases in the Ebola epidemic—Liberia and Sierra Leone, 2014–2015. MMWR Surveill Summ 2014; 63(Suppl. 3): 1–14.

Adebamowo

Bah-Sow

Binka

. Randomised controlled trials for Ebola: practical and ethical issues. Lancet 2014; 384: 1423–1424.

Cooper

Boni

Pan-ngum

. Evaluating clinical trial designs for investigational treatments of Ebola virus disease. PLoS Med 2015; 12: e1001815.

Berry

Connor

Lewis

RJ.

The platform trial: an efficient strategy for evaluating multiple treatments. JAMA 2015; 313: 1619–1620.

Meurer

Lewis

Berry

DA.

Adaptive clinical trials: a partial remedy for the therapeutic misconception?

JAMA 2012; 307: 2377–2378.

Luce

Kramer

Goodman

. Rethinking randomized clinical trials for comparative effectiveness research: the need for transformational change. Ann Intern Med 2009; 151: 206–209.